<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126096</url>
  </required_header>
  <id_info>
    <org_study_id>19-002587</org_study_id>
    <nct_id>NCT04126096</nct_id>
  </id_info>
  <brief_title>Negative Predictive Value and NIC of Beta-Lactam Antibiotics.</brief_title>
  <official_title>The Negative Predictive Value and Non-irritant Skin Testing Concentrations of Beta-Lactam Containing Antibiotics Other Than Penicillin.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers are trying to evaluate how much medication is required for allergy skin
      testing and to determine the likelihood that patients with a negative test truly don't have
      an allergy to the tested drug of skin testing to commonly used antibiotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective study to accurately determine the negative predictive value
      of skin testing with beta lactam containing antibiotics other than penicillin .

      It is hypothesized that the concentrations that should be used for beta lactams are actually
      much lower than previously recommended and that the higher incidence of identifiable beta
      lactam induced allergic reactions during anesthesia in the past may be due to irritation of
      the skin rather than a true allergic reaction (false positives).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-Irritant Concentrations to common beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Determine the NIC to common beta lactam containing antibiotics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Negative Predictive Value of Intradermal Skin Testing to commonly used beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Determine Negative Predictive Value of Intradermal Skin Testing to commonly used beta lactam containing antibiotics</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Max Concentration used when skin testing to beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Close gap on the variability of the maximal concentration used when skin testing beta lactam containing antibiotics.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Allergy</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study team is developing a new diagnostic skin testing procedure for patients who receive beta lactam containing antibiotics during surgery (other than penicillin) in order to determine Negative Predictive Values and Non-Irritant Concentrations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Skin Testing</intervention_name>
    <description>Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adults &gt; or = to 18 y/o undergoing surgery

        Exclusion Criteria:

          -  Minors under the age of 18 y/o, Adults unable to consent, or those Adults with
             previous allergic reaction history during previous surgeries.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexei Gonzalez Estrada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <phone>904-953-2451</phone>
      <email>gonzalez.alexei@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <phone>904-953-3767</phone>
      <email>Carrillo-Martin@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <phone>904-953-2451</phone>
      <email>gonzalez.alexei@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <phone>904-953-3767</phone>
      <email>Carrillo-Martin.Isamel@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexei Gonzalez Estrada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismael Carrillo-Martin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>October 11, 2019</last_update_submitted>
  <last_update_submitted_qc>October 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Alexei Gonzalez Estrada</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

